FIPRA International SRL (FIPRA)

Lobbying Organisation FIPRA International SRL

Date published 16 Sep, 2025

Relevant Matter Legislation

Public Policy Area EU Affairs

Period 1 May, 2025 to 31 Aug, 2025

Specific Details Revision of the General Pharmaceutical Legislation

Intended results Presenting the position of the European Alliance for Transformative Therapies (TRANSFORM) on the revision of the general pharmaceutical legislation.

Name of person primarily responsible for lobbying on this activity Laura Savini

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? Yes

Client(s)

Client 1

Company name European Confederation of Pharmaceutical Entrepreneurs AISBL

CRO number (if applicable)

Company address Rue Marie de Bourgogne 58 1000 Brussels Belgium

Main business or activity

Company website eucope.org

Contact email address maertens@eucope.org

Contact phone number +32 2 842 69 82

Contact address

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Virtual Meeting (1)

Online Round Table supported by Members of the European Parliament between TRANSFORM Alliance members and Irish officials.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Billy Kelleher MEP (European Parliament)

Sean Kelly MEP (European Parliament)